Cancer Research  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 35, 3014-3020, November 1, 1975]
© 1975 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilkinson, D. S.
Right arrow Articles by Hanas, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilkinson, D. S.
Right arrow Articles by Hanas, R. J.

The Inhibition of Ribosomal RNA Synthesis and Maturation in Novikoff Hepatoma Cells by 5-Fluorouridine1

David S. Wilkinson2, Thea D. Tlsty and R. Jane Hanas

Department of Biochemistry, College of Medicine, University of South Florida, Tampa, Florida 33620

2 To whom correspondence should be addressed.

The inhibition of ribosomal RNA (rRNA) maturation by 5-fluorouridine (FUrd) in Novikoff hepatoma cells appears to depend upon the incorporation of the analog into the 45 S rRNA precursor. Precursor synthesized in the presence of FUrd is not processed into mature rRNA, but precursor synthesized in the absence of the analog is processed normally after the addition of the drug. The effect of FUrd on rRNA maturation is concentration dependent. At a concentration of 1 x 10–4 M, the analog completely inhibits the formation of mature 18 S and 28 S rRNA; while at a concentration of 1 x 10–7 M, the analog has no significant effect on rRNA maturation. These results suggest that some minimum degree of analog substitution is necessary to inhibit the maturation process. In addition to its inhibition of maturation, FUrd also inhibits the transcription of 45 S rRNA precursor. However, this effect of the drug is less complete and more time dependent than the effect on maturation. The inhibition of rRNA maturation by FUrd persists after removal of the analog from the culture medium. Cells that had been exposed to FUrd for 2 hr were unable to process 45 S rRNA precursor 20 hr after removal of the drug from the medium.

1 Research supported by Grants DRG-1220 from the Damon Runyon-Walter Winchell Cancer Fund and F73FS-2 from the American Cancer Society, Florida Division, Inc.

Received 5/12/75. Accepted 7/17/75.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
D. G. Pestov, Z. Strezoska, and L. F. Lau
Evidence of p53-Dependent Cross-Talk between Ribosome Biogenesis and the Cell Cycle: Effects of Nucleolar Protein Bop1 on G1/S Transition
Mol. Cell. Biol., July 1, 2001; 21(13): 4246 - 4255.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Z. Strezoska, D. G. Pestov, and L. F. Lau
Bop1 Is a Mouse WD40 Repeat Nucleolar Protein Involved in 28S and 5.8S rRNA Processing and 60S Ribosome Biogenesis
Mol. Cell. Biol., August 1, 2000; 20(15): 5516 - 5528.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1975 by the American Association for Cancer Research.